Advancing the global public health agenda for NAFLD: a consensus statement

Jeffrey V. Lazarus,Henry E. Mark,Quentin M. Anstee,Juan Pablo Arab,Rachel L. Batterham,Laurent Castera,Helena Cortez-Pinto,Javier Crespo,Kenneth Cusi,M. Ashworth Dirac,Sven Francque,Jacob George,Hannes Hagström,Terry T.-K. Huang,Mona H. Ismail,Achim Kautz,Shiv Kumar Sarin,Rohit Loomba,Veronica Miller,Philip N. Newsome,Michael Ninburg,Ponsiano Ocama,Vlad Ratziu,Mary Rinella,Diana Romero,Manuel Romero-Gómez,Jörn M. Schattenberg,Emmanuel A. Tsochatzis,Luca Valenti,Vincent Wai-Sun Wong,Yusuf Yilmaz,Zobair M. Younossi,Shira Zelber-Sagi,Fredrik Åberg,Leon Adams,Maryam Salem Al Khatry,Khalid Al Naamani,Omar Alfaro Murillo,Alina M. Allen,Faisal Alnaser,Saleh A. Alqahtani,Khalid Alswat,Domenico Alvaro,Raúl J. Andrade,Marco Arrese,Yaw Asante Awuku,Motala Ayesha,Oidov Baatarkhuu,Shokhista Bakieva,Rita Basu,Ramon Bataller,Shahinaz Bedri,Emanuele Bosi,Marc Bourliere,Radan Bruha,Elisabetta Bugianesi,Patrizia Burra,Maria Buti,Christopher D. Byrne,Jose Luis Calleja,Patrizia Carrieri,Flloyd Carter,Marlen Ivon Castellanos Fernandez,Gabriela Castillo-Lopez,Graciela E. Castro-Narro,Henry Lik Yuen Chan,Wah-Kheong Chan,Yoosoo Chang,Massimo Colombo,Kirsten J. Coppell,Kathleen Corey,Antonio Craxi,Donna Cryer,Anuradha Dassanayake,Antonieta de Ascenção Soares Martins,Victor de Ledinghen,Stefano DelPrato,Alessandro Demaio,Hailemichael Desalegn,John Dillon,Ajay Duseja,Prabhakaran Dorairaj,Mattias Ekstedt,Mohamed El Kassas,Osama M. Elsanousi,Gamal Esmat,Jian-Gao Fan,Nathalie Farpour-Lambert,Robert Flisiak,Yasser Fouad,Michael Fuchs,Rino A. Gani,Lynn Gerber,Hasmik Ghazinyan,Liana Gheorghe,George Boon-Bee Goh,Henning Grønbæk,Aghayeva Gulnara,Saeed Hamid,Vanessa Hebditch,Ingrid J. Hickman,Samantha L. Hocking,Bela Hunyady,Ramazan Idilman,Vasily A. Isakov,Mohammad H. Jamal,Peter Jepsen,Natacha Jreige Iskandar,Myeong Jun Song,K. C. Sudhamshu,Satoru Kakizaki,George Kalamitsis,Fasiha Kanwal,Jia-Horng Kao,Lee Kaplan,Takumi Kawaguchi,Yousef Khader,Seung Up Kim,Nicolas Kodjoh,Ger Koek,Kazuhiko Koike,Narcisse Patrice Komas,Marko Korenjak,Marcelo Kugelmas,Asma Labidi,Naomi F. Lange,Joel E. Lavine,Mariana Lazo,Nancy Lee,Cosmas Rinaldi A. Lesmana,Chun-Jen Liu,Michelle T. Long,Patricio Lopez-Jaramillo,Reza Malekzadeh,Mamun Al Mahtab,Giulio Marchesini,Rui Marinho,Sophia E. Martínez Vázquez,Lyudmila Mateva,Charles Mbendi Nlombi,Pascal Melin,Ivana Mikolasevic,Tamara Milovanovic,Carla Musso,Atsushi Nakajima,Edna Nava,Alexander V. Nersesov,Dafina Nikolova,Suzanne Norris,Katja Novak,Jude Oben,Janus P. Ong,Charles Onyekwere,George Papatheodoridis,Imran Paruk,Keyur Patel,M. Paula Macedo,Carlos Penha-Gonçalves,Marlene Pérez Figueroa,Wolf Peter Hofmann,Salvatore Petta,Claudia Pinto Marques Souza de Oliveira,Puneet Puri,Calvin Q. Pan,Marek Rac,Johanna Ralston,Alnoor Ramji,Homie Razavi,Mario Reis Alvares-da-Silva,Stuart Roberts,Michael Roden,Tamsin Rose,Samir Rouabhia,Patrizia Rovere-Querini,Ian A. Rowe,Shakhlo Sadirova,Riina Salupere,Tobokalova Saparbu,Raymond Sayegh,Giada Sebastiani,Yosuke Seki,Josefina Selmo,Abdel Karim Serme,Jonathan E. Shaw,Thrivikrama Shenoy,Nick Sheron,Oren Shibolet,Marcelo Silva,Igor Skrypnyk,Piotr Socha,Joan Soriano,C. Wendy Spearman,Kannan Sridharan,Juan José Suárez,Dhastagir Sultan Sheriff,Ki-Chul Sung,Mark Swain,Frank Tacke,Shahrad Taheri,Soek-Siam Tan,Elliot B. Tapper,Hannele Yki-Järvinen,Maja Thiele,Isaac Thom Shawa,Ieva Tolmane,Esther A. Torres,Michael Trauner,Sombat Treeprasertsuk,Adela Turcanu,Jonas Valantinas,Mette Vesterhus,Imam Waked,Sarah H. Wild,Jose Willemse,Robert J. Wong,Stavra Xanthakos,Dan Yock Young,Ming-Lung Yu,Kenneth I. Zheng,Mudjat Zeybel,Ming-Hua Zheng,,
DOI: https://doi.org/10.1038/s41575-021-00523-4
2021-10-27
Abstract:Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics — from epidemiology, awareness, care and treatment to public health policies and leadership — that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD.
gastroenterology & hepatology
What problem does this paper attempt to address?